Antihuman factor V antibodies after use of relatively pure bovine thrombin

Annals of Thoracic Surgery

Volumn 79, Issue 3, 2005, Pages 1037-1038

  Lawson, Jeffrey H ^a   Lynn, Kellie A ^a   Vanmatre, Reed M ^a   Domzalski, Taymon ^a   Klemp, Keith F ^a   Ortel, Thomas L ^a   Niklason, Laura E ^a   Parker, William ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODY; BLOOD CLOTTING FACTOR 5; BLOOD CLOTTING FACTOR 5 ANTIBODY; THROMBIN; UNCLASSIFIED DRUG;

AGED; ANTIBODY PRODUCTION; ARTERY CLAMP; ARTICLE; BLOOD CLOTTING DISORDER; CASE REPORT; CLINICAL FEATURE; CORONARY ARTERY BYPASS SURGERY; CORONARY ARTERY DISEASE; HUMAN; MALE; PARTIAL THROMBOPLASTIN TIME; PRIORITY JOURNAL; PROTHROMBIN TIME; SURGICAL WOUND; TREATMENT OUTCOME;

EID: 14244252558     PISSN: 00034975     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.athoracsur.2003.09.110     Document Type: Article

References (6)

1. Schoenecker J.G., Hauck R.K., Mercer M.C., et al. Exposure to topical bovine thrombin during surgery elicits a response against the xenogeneic carbohydrate galactose (alpha1-3) galactose. J Clin Immunol. 20:2000;434-444
2. Schoenecker J.G., Johnson R.K., Lesher A.P., et al. Exposure of mice to topical bovine thrombin induces systemic autoimmunity. Am J Pathol. 159:2001;1957-1969
3. Banninger H., Hardegger T., Tobler A., et al. Fibrin glue in surgery frequent development of inhibitors of bovine thrombin and human factor V. Br J Hematol. 85:1993;528-532
4. Knobl P., Lechner K. Acquired factor V inhibitors. Baillieres Clin Hematol. 11:1998;305-318
5. Dorion R.P., Hamati H.F., Landis B., et al. Risk and clinical significance of developing antibodies induced by topical thrombin preparations. Arch Pathol Lab Med. 122:1998;887-894
6. Tadokoro K., Ohtoshi T., Takafuji S., et al. Topical thrombin-induced IgE-mediated anaphylaxis. RAST analysis and skin test studies. J Allergy Clin Immunol. 88:1991;620-629